Search Results 1421-1430 of 13320 for monoclonal antibody

1. Breast Cancer Biomarker Sample Collection For The DtectDx V2 Assay Proof Of Concept Protocol - Mayo Clinic

   ... antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for ...

2. Study Assessing Safety And Efficacy Of Combination Of BL-8040 And Pembrolizumab In Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

   Has had a prior anti-cancer monoclonal antibody within 4 weeks prior to ... Has a known history of HIV (HIV 1/2 antibodies). Has known active Hepatitis ...

3. Cyclophosphamide and Vaccine Therapy in Treating Patients with Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Anti-nuclear antibody (ANA) - negative or ≤ normal institutional range ... monoclonal antibodies, small molecule inhibitors) for this cancer; Known ...

4. Combination Study Of SV-BR-1-GM In Combination With INCMGA00012 And Retifanlimab - Mayo Clinic

   Known hypersensitivity to another monoclonal antibody that cannot be controlled with standard measures (e.g., antihistamines and corticosteroids) or known ...

5. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors - Mayo Clinic

   ... monoclonal antibody (mAb) therapy within 45 days prior to study Day 1. Note: Patients are allowed to receive any of the following treatments up to 7 days ...

6. Clinical trials - Oncology (Medical)

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

7. Exploring The Role Of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) In BAFFR-expressing B-cell Hematologic Malignancies And Autoimmune Rheumatologic Disorders - Mayo Clinic

   ... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. Participation eligibility. Participant eligibility ...

8. Mayo Clinic Minute: What is CAR-T cell therapy?

   Patients who are newly diagnosed with lymphoma are offered a combination of chemotherapy and antibody-based treatments. But for those who do not respond to ...

9. A Study Of Pirtobrutinib And Brexucabtagene Autoleucel In Relapsed Or Refractory Mantle Cell Lymphoma - Mayo Clinic

   Targeted agents (i.e. BTK inhibitors), investigational agents, therapeutic monoclonal antibodies ... Antibody-drug conjugates (ADC): 10 weeks. Radiation ...

10. High blood protein When to see a doctor - Mayo Clinic

    https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis. Accessed Sept. 16, 2024. Monoclonal gammopathy of undetermined significance (MGUS).